UNSPSC 51453205: Pyrvinium chloride

This classification denotes an antihelminthic agent with the molecular structure C26H28N3.CL, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, MT7O310S39 chemically known as 6-dimethylamino-2'-(2-(2,5-dimethyl-1-phenyl-3-pyrrolyl)vinyl)-1-methylquinolinium chloride, but more commonly known as pyrvinium chloride, which bears US NIH Compound Identifier 6436141. European Medicines Agency schedules Pyrvinium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10183MIG.

UNSPSC 51453205 Pyrvinium chloride is a Commodity code that captures pharmaceutical active ingredients and finished pharmaceutical products procured by state and local health and public health agencies. The recent opportunities recorded under this code do not reflect pyrvinium chloride directly; instead, they show state and local governments purchasing finished pharmaceutical products—antibiotics, opioid antagonists, and related health-system consumables—through competitive bidding processes, often leveraging cooperative purchasing agreements and multistate consortia. The Illinois Department of Public Health procured antibiotics (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets) through a piggyback contract with Chartwell Rx LLC awarded under an Invitation for Bid process, while Seminole County, Florida issued a competitive IFB for naloxone and drug deactivation systems with annual volumes specified at 1,900 units and 800 units respectively. The issuing bodies under this code are primarily state departments of health and county public health agencies seeking routine pharmaceutical supply and emergency medical response inventory.

Activity is centered in Florida and Illinois based on the recent opportunities, though the sample size is limited. The Illinois Department of Public Health contract, awarded in August 2026 for $2,999,999.11 over three years with renewal options, demonstrates steady state-level demand for pharmaceuticals through consortium purchasing vehicles such as MMCAP Infuse. Seminole County's IFB, posted in June 2026 with a response deadline of July 26, 2026, targets quarterly deliveries of naloxone and deactivation systems to support community health initiatives, with potential FEMA funding and associated federal compliance requirements. Neither opportunity specified set-asides for disadvantaged enterprises, though both required E-Verify compliance and standard insurance certifications. No other recent opportunities under this code are present in the source; activity appears sparse and episodic rather than representing a high-volume or actively competitive procurement category.